Eugia Pharma Specialities receives 7 observations from USFDA for Unit II

The United States Food and Drug Administration (US FDA) inspected Unit-II, a Formulation manufacturing facility, of Eugia Pharma Specialities Ltd., a wholly owned subsidiary of Aurbindo Pharma Ltd, situated at Bhiwadi, Alwar, Rajasthan, from April 25th to May 3rd 2024.

The inspection closed with 7 observations. The observations are procedural in nature and will be responded to within the stipulated time.

IOL Chemicals and Pharmaceuticals receives GMP certificate from ANVISA

IOL Chemicals and Pharmaceuticals Limited has received Certificate of Good Manufacturing Practices (GMP) from Brazilian Health Regulatory Agency (ANVISA) for all the 10 APIs manufacturing Units situated at Barnala, Punjab.